Kelly Bayer Rosmarin to Lead Australian Unity as New CEO from December 2025

Leadership Transition Marks New Chapter

Australian Unity Limited (ASX, AYU) has announced a significant leadership change with the appointment of Ms Kelly Bayer Rosmarin as the new Group Managing Director and Chief Executive Officer. She will succeed Mr Rohan Mead, who is retiring after an impressive 21-year tenure at the helm. This transition signals a pivotal moment for the mutual company as it embarks on a new phase of strategic growth and transformation.

Ms Bayer Rosmarin’s official commencement date is set for 15 December 2025, following a transition period alongside Mr Mead starting 5 November 2025. The board’s unanimous decision came after a rigorous selection process involving both internal and external candidates, underscoring their confidence in her ability to lead the organisation forward.

A Proven Leader with Broad Industry Experience

Bringing a wealth of executive experience, Ms Bayer Rosmarin has held senior roles at major Australian companies including Optus, Commonwealth Bank of Australia, and the REA Group. Her background spans management consulting, digital innovation, and large-scale transformation programs, positioning her well to navigate the evolving landscape of health, wealth, and care services that Australian Unity operates within.

Her leadership style, described by Australian Unity Chair Lisa Chung AM as a compelling blend of care, intellect, and business acumen, aligns closely with the company’s values and vision. Ms Bayer Rosmarin’s track record of unlocking growth through innovation is expected to be a key asset as Australian Unity responds to demographic shifts and increasing demand for its services.

Strategic Growth Amidst Demographic Change

Australian Unity is currently undertaking a significant transformation program aimed at strengthening its position as a national leader in wellbeing. The appointment of Ms Bayer Rosmarin comes at a time when the organisation is preparing to meet rising demand driven by demographic trends, including an ageing population and evolving consumer expectations around health and financial services.

Ms Bayer Rosmarin expressed pride in joining a values-driven organisation with a proud legacy. She highlighted the opportunity to lead Australian Unity through its next chapter, focusing on innovation and impact to improve outcomes for members, customers, and the broader community.

Looking Ahead

As Australian Unity transitions leadership, the market will be watching closely to see how Ms Bayer Rosmarin’s vision and experience translate into tangible growth and innovation. The company’s commitment to its mutual status and purpose-led approach remains a cornerstone, even as it adapts to new challenges and opportunities in the wellbeing sector.